A few minutes ago I circulated a paper from Health Policy and Planning. I have now received a second paper that is relevant to this subject, thanks to the Maternal Health Task Force. It is a reminder of the importance of economic factors in country-level policymaking.
CITATION: Lancet Glob Health 2020 Oct 30;S2214-109X(20)30369-7. doi: 10.1016/S2214-109X(20)30369-7. Online ahead of print.
Cost-effectiveness of intermittent preventive treatment with dihydroartemisinin-piperaquine for malaria during pregnancy: an analysis using efficacy results from Uganda and Kenya, and pooled data
Silke Fernandes, Vincent Were, Julie Gutman et al.
PMID: 33137287 DOI: 10.1016/S2214-109X(20)30369-7
SUMMARY: Cost-effectiveness of intermittent preventive treatment with dihydroartemisinin-piperaquine for malaria during pregnancy: an analysis using efficacy results from Uganda and Kenya, and pooled data
Lancet Glob Health The authors conducted a cost-effectiveness analysis of intermittent preventive treatment for malaria in pregnancy. They used data from three clinical trials to calculate neonatal death, mild and moderate maternal anemia, disability-adjusted life-years (DALYs) from stillbirths, clinical malaria infection, and low birthweight. They found that three doses of dihydroartemisinin-piperaquine (IPTp-DP) administered to a hypothetical cohort of 1000 pregnant women averted 892 DALYs at US$7,051 as the incremental cost, when compared to the same dose of sulfadoxine-pyrimethamine (IPTp-SP). Additionally, monthly doses of IPTp-DP averted 534 DALYs at US$13,427, when compared to the same dose of IPTp-SP. They conclude that IPTp-DP is cost-effective in places with high malaria transmission and IPTp-SP resistance.
Best wishes, Neil
Coordinator, HIFA Project on Evidence-Informed Policy and Practice
Let's build a future where people are no longer dying for lack of healthcare information - Join HIFA: www.hifa.org
HIFA profile: Neil Pakenham-Walsh is coordinator of the HIFA global health campaign (Healthcare Information For All - www.hifa.org ), a global community with more than 20,000 members in 180 countries, interacting on six global forums in four languages in collaboration with WHO. Twitter: @hifa_org FB: facebook.com/HIFAdotORG email@example.com